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Summary
Objective: It is widely believed that there are multiple sources of pain at a tissue level in osteoarthritis (OA). Magnetic Resonance Images
(MRIs) provide a wealth of anatomic information and may allow identiﬁcation of speciﬁc features associated with pain. We hypothesized
that in knees with OA, bone marrow lesions (BMLs), synovitis, and effusion would be associated with weight-bearing and (less so with)
non-weight-bearing pain independently.
Methods: In a cross-sectional study of persons with symptomatic knee OA using univariate and multivariate logistic regressions with maximal
BML, effusion, and synovitis deﬁned by Boston Leeds Osteoarthritis Knee Score as predictors, and knee pain using weight-bearing and non-
weight-bearing Western Ontario and McMaster University OA Index pain questions as the outcome, we tested the association between MRI
ﬁndings and knee symptoms.
Results: 160 participants, mean age 61 (9.9), mean body mass index (BMI) 30.3 (4.7) and 50% female, stronger associations were seen
with weight-bearing compared with non-weight-bearing knee pain with adjusted risk ratios (RRs) of weight-bearing knee pain, for increasing
maximal BML scores of 1.0 (referent) (maximal BML¼ 0), 1.2, 1.9, and 2.0 (P for trend¼ 0.006). For effusion scores, adjusted RRs of knee
pain were 1.0, 1.7, 2.0, and 2.6 (P for trend¼ 0.0004); and for synovitis scores, adjusted ORs were 1.0, 1.4, 1.5, and 1.9 (P for trend¼ 0.22).
Conclusion: Cross-sectionally, maximal BML and effusion scores are independently associated with weight-bearing and less so with non-
weight-bearing knee pain, supporting the idea that pain in OA is multifactorial. These MRI features should be considered as possible new
treatment targets in knee OA.
ª 2009 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Osteoarthritis (OA) is the most common form of arthritis1
and is one of the most common causes of disability in
the elderly2. To date, there are few effective treatments
for knee OA. This may in large part be related to the fact
that the identiﬁcation of speciﬁc tissue level of pain in
OA has been difﬁcult and thus analgesic approaches
have been non-speciﬁc in their approach to pain. However,
Magnetic Resonance Images (MRIs) provide a wealth of
anatomic information and may allow identiﬁcation of spe-
ciﬁc features associated with pain, particularly with the ad-
vent of higher strength magnets (3 T) that are now being
used in the clinical setting. As there are many possible*Address correspondence and reprint requests to: Grace H. Lo,
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1562etiologies of pain in OA, it is important to look at potential
sources of pain both individually and collectively. Such
sources may include bone marrow lesions (BMLs), synovi-
tis, and synovial effusion.
The BML is a feature associated with OA that has only
been identiﬁed since MRIs have been used to image join-
ts3e9. Because BMLs are localized in the subchondral
bone and the subchondral bone is innervated10,11, this is
a potential source of pain in OA. Prior clinical investigations
of BMLs as a source of pain in OA have produced conﬂict-
ing results. Some studies have shown an association with
pain12,13, while others have suggested that the relationship
with pain is questionable9,14e17.
Synovitis is more recently gaining attention as an impor-
tant feature in OA13,18e21. As an innervated tissue22e25, in-
ﬂammation of the synovium may be a cause of pain.
Synovial effusions have long been known to be a feature
of OA. There have been a few studies which suggest these
effusions contribute to knee pain in OA13,19, though one
study13 did not distinguish synovitis and synovial effusion
1563Osteoarthritis and Cartilage Vol. 17, No. 12when looking at their relationship with pain. Intuitively, we
would expect effusion to be associated with pain as the joint
capsule is richly innervated26,27, and with a substantive ef-
fusion, the joint capsule is distended. Many prior stud-
ies3,9,12,14 have evaluated the contribution of each tissue
individually to pain but to our knowledge, none has taken
into account the whole joint nature of OA and the potential
for multiple tissues to contribute to pain within one knee.
Part of the difﬁculty in disentangling sources of pain in OA is
the fact that thedeﬁnitionof pain inOAhasbeenproblematic. In
fact, Outcome Measures in Rheumatology, originally termed
Outcome Measures in Rheumatoid Arthritis Clinical Trials
(OMERACT), has undertaken the task of reevaluating the out-
come of pain inOA in part for this reason. Highlighting these is-
sues are the results of a recent factor analysis28 of theWestern
Ontario McMaster Universities Osteoarthritis Index (WOMAC)
pain scale29,30, one of the most widely used assessments of
pain in knee OA31, suggested that the WOMAC pain scale
does not represent one construct. The weight-bearing items
represent one factor and the non-weight-bearing items repre-
sent a second factor. Because pain in OA is generally charac-
terized as pain that occurs on weight-bearing, a deﬁnition of
pain focusing on the weight-bearing WOMAC questions is po-
tentially a better strategy to summing all ﬁve-item responses.
We hypothesized that in people with OA, BMLs, synovitis,
and effusion, as visualized on MRI, would be independently
associated with weight-bearing and (less so with) non-
weight-bearing pain.MethodsSAMPLE SELECTIONThe Osteoarthritis Initiative (OAI) is a publicly available multi-center ob-
servational study of knee OA of 4796 participants, which is comprised of
three groups, the progression (N¼ 1389), the incidence (N¼ 3285), and
a non-exposed control group (N¼ 122). The ‘‘progression cohort’’ all have
pre-existent symptomatic radiographic knee OA (ROA), the ‘‘incident cohort’’
are at high risk for symptomatic ROA, and the ‘‘non-exposed control group’’
do not have nor are at high risk for symptomatic ROA. For this study, we spe-
ciﬁcally focused on the baseline assessments of the progression group, iden-
tiﬁed using the inclusion criteria of ages 45e79; and having at least one knee
with both radiographic evidence of knee OA (Osteoarthritis Research Society
International (OARSI) atlas osteophyte grade 1e3) and symptoms (‘‘pain,
aching or stiffness on most days of the month in the last year’’). Those
with evidence of severe joint space narrowing (JSN), as deﬁned by OARSI
atlas JSN grade 3, in both knees were excluded.
Participants received assessments of knee-speciﬁc WOMAC pain, poste-
rior-anterior semi-ﬂexed radiographs32 of bilateral knees, and MRIs of bilateral
knees.EachMRIwasobtainedononeof four identicalSiemensTrio3 TMRIsat
one of the four clinical sites,Memorial Hospital of Rhode Island (Pawtucket,RI),
Ohio State University (Columbus, Ohio), University of Pittsburgh (Pittsburgh,
PA), and University of Maryland/Johns Hopkins University (Baltimore, MD).
From the 1389 participants in the progression cohort, 160 were identiﬁed
and selected by the OAI Coordinating Center as part of the public release
MRI data set 0.B.1, a convenience sample of people with high quality
MRIs, blocked for sex, ethnicity, and clinical center, all of whom had com-
plete baseline and year 1 follow-up MRIs. All those in data set 0.B.1 were in-
cluded in this study. Baseline demographic data as well as WOMAC pain
were obtained from data set 0.1.1, accessed from the website, http://
www.oai.ucsf.edu/datarelease.KNEE SELECTIONFrom the participants included, we chose one knee to evaluate per indi-
vidual. Eligible knees were those of the 160 with symptomatic radiographic
OA as described above in Sample selection. For individuals with bilateral
symptomatic radiographic OA, we selected one knee, preferentially selecting
those with a Kellgren/Lawrence (KL) score grades 2 or 3, with a greater
anatomic axis varus angulation, and with medial tibiofemoral (TF) OA.
The radiographic assessments from one unadjudicated reader (DH) were
available and used to select the knee from a participant used in this study. In
the 100 patients with unilateral symptomatic ROA, this knee was chosen for
analysis, regardless of radiographic severity. For the remaining participantswith bilateral symptomatic ROA, one knee was selected, favoring the knee
with moderate disease. In patients with bilateral symptomatic ROA, if only
one knee had KL grade 2 or 3 then that knee was selected. If both knees
had KL grade 2 or 3, then the knee with the greatest extent of each of the
following features was selected, moving to the next feature if the knees
were still ranked as equal:
 Greater anatomic axis varus angulation 2.0 mm medial minimum Joint Space Width (JSW) Greater grade of medial JSN (grades 1e3) The presence of any medial tibial or femoral osteophyte grade 2 with
greater grade than lateral osteophytes The presence of any medial tibial or femoral osteophyte The right knee
If neither knee was KL grade 2 or 3, then the knee with the higher KL
grade was chosen. If the patient had bilateral KL grade 0, 1 or 4 knees,
then the process used to select among bilateral KL grade 2 or 3 knees
was followed. Next, knees were listed on the basis of decreasing KL grade,
and within KL grade by decreasing varus angulation.MRI READINGThe time point of interest for this study was the baseline visit. Two rheu-
matologists experienced in musculoskeletal MRI readings, both of whom
were centrally involved in the development of the Boston Leeds Osteoarthritis
Knee Score (BLOKS)12, blinded to subject data, scored one knee MRI from
each participant for BMLs, synovitis, and effusion using BLOKS. One reader
(GHL) scored BMLs and the other (DJH) scored synovitis and effusion.
We deﬁned a BML [Fig. 1(A)] as an irregular hyperintense signal in the
subchondral bone, proximal to the epiphyseal line, as seen on sagittal inter-
mediate-weighted (IW) Turbo Spin Echo (TSE) fat-suppressed images (FS),
time to recovery (TR) of 3200 ms, time to echo (TE) of 30 ms, slice thickness
of 3 mm, and ﬁeld of view (FOV) of 160 mm (Table I). We also used Dual
Echo in the Steady State (DESS) sequences to assist with localization of
some lesions (Table I). BMLs were scored for size (0e3) at each of nine lo-
cations, medial and lateral patella, medial and lateral trochlea, medial and
lateral weight-bearing femur, and medial, subspinous, and lateral tibia.
Only those BMLs with greater than 25% of the surface area adjacent to
the subchondral plate were included. To assess intra-rater reliability, a sam-
ple of 10 knee MRIs were read for BMLs twice by the same reader separated
by at least 2 days for a weighted kappa of 0.88. From the nine regions scored
for BML size, each knee was given a maximal BML score.
We identiﬁed synovial effusion [Fig. 1(B)] as hyperintense signal within the
joint capsule. Effusion was scored from 0 to 3 (0¼ physiologic effusion,
1¼ small effusion, 2¼moderate effusion, 3¼ large effusion). This feature
was scored using axial MPR DESS sequences (Table I). To assess intra-rater
reliability, a sample of 20 knee MRIs were read for synovial effusion twice by
the same reader separated by at least 2 weeks for a weighted kappa of 0.60.
We also looked at synovitis [Fig. 1(C)] in the infrapatellar fat pad, hyper-
intense signal in the infrapatellar fat pad as seen on the same sequences
used to evaluate BMLs (see above). Synovitis was scored from 0 to 3
(0¼ none, 1¼mild, 2¼moderate, 3¼ severe). To assess intra-rater reliabil-
ity, a sample of 20 knee MRIs were read for synovitis twice by the same
reader separated by at least 2 weeks for a weighted kappa of 0.64.PAIN ASSESSMENTBecause pain related to knee OA is clinically expected to occur during
weight-bearing and because a recent factor analysis of the ﬁve WOMAC
pain questions suggested that there are two constructs within the ﬁve ques-
tions28, we deﬁned the primary outcome of knee pain dichotomously as mod-
erate to severe pain (scores 2e4) of any of the three weight-bearing
WOMAC pain questions (pain on climbing stairs, on walking, and on stand-
ing). We deﬁned pain dichotomously as moderate to severe pain (scores
2e4) of any of the two non-weight-bearing WOMAC pain questions (pain
in bed or with sitting/lying down) as our secondary outcome.STATISTICAL ANALYSISFirst we computed Spearman Correlation Coefﬁcients comparing maximal
BML size, synovitis and effusion. We then performed univariate Cox regres-
sion with constant follow-up and robust variation estimation as a means for
calculating relative risk ratios (RRs)33 evaluating maximal BML size, synovi-
tis, and effusion as independent variables (via dummy variables34) and
weight-bearing knee pain as the dependent variable, our primary outcome.
We then performed multivariate analyses including all three predictors. Sub-
sequently, age, sex, and body mass index (BMI) were added into the
models. We repeated all regression analyses using non-weight-bearing
knee pain as the dependent variable, our secondary outcome.
Fig. 1. (A) Sagittal MRIs of the knee. The left MRI is of a knee without any BMLs. The right MRI is of a knee with a large BML in the lateral
patella and lateral trochlea (yellow arrows). (B) Axial MRIs of the knee. The left MRI is of a knee with a physiologic effusion. The right MRI is of
a knee with a large joint effusion. (C) Sagittal MRIs of the knee. The left MRI is of a knee without any infrapatellar synovitis. The right MRI is of
a knee with a large amount of synovitis in the infrapatellar fat pad (yellow circles).
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(version 9.1; SAS Institute, Cary, NC). P-values 0.05 were considered sta-
tistically signiﬁcant.Results
160 participants were included in the study, mean age
(61 9.9),meanBMI (30.3 4.7), 50% female, 82.5%white,
15.6% black/African American, and 1.9% other race. The
overall prevalence of maximal BML 1¼ 91.1%, effusionscore 1¼ 83.7%, and synovitis score 1¼ 95.6%
(Table II). The correlation between maximal BML and effu-
sion score was an r¼ 0.21 (P¼ 0.0066); between maximal
BML and synovitis was an r¼ 0.004 (P¼ 0.95); between sy-
novitis and effusion was r¼ 0.10 (P¼ 0.20).
Maximal BML score was positively associated with preva-
lence of knee pain (Table III). Compared with knees having
a maximal BML score of 0, the risk of having pain in a knee
increased progressively with increase in BML score (P for
trend¼ 0.0009; see Table III). These RRs did not change
Table I
MRI parameters
Weighting 3-Plane
T1W
2D TSE
Int
3D DESS
T2 with magnetic susceptibility
2D TSE
Int
Plane 3-Plane Coronal Sag Sagittal
Fat Sat No No WE Yes
Matrix (phase) 256 307 307 313
Matrix (freq) 512 384 384 448
No. of slices 21 41 160 37
FOV (mm) 200 140 140 160
Slice thickness (mm) 5 3 0.7 3
Ship (mm) 1 0 0 0
Flip Angle (deg) 40 180 25 180
TE/TI (ms) 5 29 4.7 30
TR (ms) 10 3850 16.3 3200
BW (Hz/pixel) 250 352 185 248
Chemical Shift (pixels) 1.8 1.3 0 0
NAV (NEX) 1 1 1 1
Echo train length 1 7 1 5
Phase Encode Axis A/P, R/L R/L A/P S/I
Phase Partial Fourier (8/8¼ 1) 1 1 0.875 1
Readout Partial Fourier (8/8¼ 1) 1 1 1.000 1
Slice Partial Fourier (8/8¼ 1) 1 1 0.875 1
Options Elliptical k-space ﬁlter
and large FOV ﬁlter
Elliptical k-space ﬁlter,
elliptical sampling,
large FOV ﬁlter
Elliptical k-space ﬁlter
and large FOV ﬁlter
Distance Factor (%) 50 0 0 0
Phase Oversampling 0 20 0 40
Slice Oversampling 0 0 10 0
Phase Resolution 50 80 80 70
Averaging Technique Short term Short term Short term Short term
Gradient Rise Time Fast Fast Fast Fast
RF Amplitude Normal Normal Fast Normal
X-Resolution (mm) 0.391 0.365 0365 0.357
V-Resolution (mm) 0.781 0.456 0.456 0.511
Calc time (min) 2.7 3.4 11.2 47
Scan time (min) 0.5 3.4 10.6 4.7
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effusion (Table III), or after adjustment for age, sex, and
BMI into the model (results not shown).
Similarly, effusion score was positively associated with
prevalence of knee pain (Table III). Comparedwith knees hav-
ing an effusion score of 0, the risk of having pain in a knee in-
creased progressively with increase in effusion score (P for
trend< 0.0001; seeTable III). TheseRRswereslightly smaller
after adjustment for presence of maximal BML and effusion
(Table III), and essentially unchanged after adjustment for
age, sex, and BMI into the model (results not shown).
Synovitis score was also positively associated with prev-
alence of knee pain (Table III). Compared with knees hav-
ing a synovitis score of 0, the risk of having pain in
a knee increased progressively with increase in synovitis
score although the p for trend was not signiﬁcant at 0.20
(see Table III). Notably, the number of knees in the referent
group was small (n¼ 7), likely making the point estimates in
the synovitis analyses less stable. These RRs did not
change substantively after adjustment for presence of
maximal BML and effusion (Table III), or after adjustment
for age, sex, and BMI into the model (results not shown).
The results of the regression analyses evaluating non-
weight-bearing knee pain, our secondary outcome, as it re-
lates to BMLs and effusion were similar to those evaluating
our primary outcome, weight-bearing knee pain (Table IV)
where there was an increased risk of having pain in
a knee with greater BMLs and effusion scores. The main
differences included that the RRs for the relations ofBMLs and effusion with pain were smaller in magnitude
and for BMLs likely leading to the P for trend not quite meet-
ing the level of signiﬁcance. Also, in evaluating synovitis
and pain, although the P for trend was not signiﬁcant, the
RRs suggested a negative association between synovitis
and non-weight-bearing knee pain, consistent with a higher
level of synovitis being associated with less non-weight-
bearing pain, as compared to the positive association
seen when using a weight-bearing deﬁnition of knee pain.Discussion
In this cross-sectional study of 160 participants with symp-
tomatic knee OA, BMLs and synovial effusion scores were
highly associated with weight-bearing knee pain. The strength
of the associations persisted whenmutually adjusting for other
features of OA. Although other studies have looked at the rela-
tionship of different OA MRI features as they relate to
pain13,14,19, ours is the ﬁrst to look at those relationships both
in univariate as well as multivariate analyses, while also con-
trolling for the inﬂuenceof other covariates. Theseﬁndingssug-
gest that BMLs, synovial effusion, and perhaps synovitis are
features of OA, independently associated with weight-bearing
knee pain, supporting the current thinking that pain in OA is
multifactorial in etiology, that pain emanates from processes
that have some degree of independence from one another.
It has long been observed that the assessment of symp-
toms in OA can be very problematic. This has also been
Table II
Participant characteristics
Number of participants 160
Age (mean (SD)) 61 9.9
BMI (mean (SD)) 30.3 4.7
Sex 50% female
Race
White 132/160 (82.5%)
Black/African American 25/160 (15.6%)
Other 3/160 (1.9%)
WOMAC Pain Composite Score
(mean (SD)) [possible range 0e20]
5.2 3.9
Prevalence of weight-bearing
knee pain
86/160 (53.8%)
Prevalence of non-weight-bearing
knee pain
44/160 (27.5%)
Maximal bone marrow lesion scores
0 14/160 (8.8%)
1 47/160 (29.3%)
2 36/160 (22.5%)
3 63/160 (39.4%)
Effusion scores
0 26/160 (16.3%)
1 62/160 (38.7%)
2 55/160 (34.4%)
3 17/160 (10.6%)
Synovitis scores
0 7/160 (4.4%)
1 79/160 (49.4%)
2 54/160 (33.7%)
3 20/160 (12.5%)
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ments inOA.Since its validation for use in short termpharma-
cologic studies30,35,36, the WOMAC pain questionnaire has
been one of the most commonly used methods for assess-
ment of symptoms in knee OA31. However, problems have
been identiﬁed with the utilization of this outcome measure.
As mentioned previously, a recent factor analysis28 evaluat-
ing the WOMAC pain scale has shown that the ﬁve WOMAC
pain questions do not represent one construct. Instead, theyTable I
Associations of weight-bearing pain with maximal B
Prevalence of knee
pain (weight-bearing pain)
Max BML score
0 4/14 (28.6%)
1 18/47 (38.3%)
2 22/36 (61.1%)
3 42/63 (65.6%)
Effusion score
0 7/26 (26.9%)
1 30/62 (48.8%)
2 35/55 (63.6%)
3 14/17 (82.4%)
Synovitis score
0 2/7 (28.6%)
1 42/79 (53.2%)
2 29/54 (53.7%)
3 13/20 (65.0%)
*Multivariate analysis results were adjusted for the other two MRI featu
effusion and synovitis).represent two constructs, weight-bearing questions (pain
with walking on a ﬂat surface and pain with climbing stairs)
and non-weight-bearing questions (pain with sitting and
pain with lying in bed). The question of pain with standing
could have been included in either of the factors, the
weight-bearing or the non-weight-bearing questions, but as
the face validity of the assessment was more consistent
with theweight-bearing questions, we added pain with stand-
ing to our assessment of weight-bearing knee OA pain. By
utilizing this deﬁnition of pain, we have been able to detect
larger point estimates of pain as they relate to features of
OA as seen on MRI than have been seen in the past. The re-
sults of this study support the need for further exploration of
alternative methods of assessing pain in knee OA.
Because this is a newly developed deﬁnition of knee pain
in OA was created based on the results of the aforemen-
tioned factor analysis, we repeated the analyses in this study
utilizing a deﬁnition of knee pain based on the two non-
weight-bearing questions (Table IV). In these analyses, the
prevalence of knee pain was diminished in all groups. Also,
the point estimates for the RRs of knee pain were diminished
for BMLs and effusion and the P-for trend for BMLs was no
longer statistically signiﬁcant. Furthermore, in the analyses
evaluating synovitis, the RRs of knee pain while still non-sig-
niﬁcant, were now in the opposite direction of what we would
have anticipated, suggesting that increasing synovitis is as-
sociated with decreased prevalence of non-weight-bearing
pain. This means it is unlikely that there is a relationship be-
tween synovitis and non-weight-bearing knee pain. Collec-
tively, this supports that the deﬁnition of knee pain focused
on the non-weight-bearing questions is not optimal for evalu-
ating symptoms related to knee OA. Furthermore, these re-
sults re-emphasize the idea that there is a need for
alternate strategies of utilizing the WOMAC pain subscale.
BLOKS is a new scoring method designed for systemati-
cally assessing the features of knee OA as seen on MRI.
BMLs, synovitis and effusion are all features that are scored
in BLOKS. This study demonstrates that scoring of these fea-
tures utilizingBLOKShas a strong associationwith knee pain
cross-sectionally, providing validation for the BLOKS scoring
method for these features. Further systematic evaluation ofII
ML score, effusion score and synovitis score
Univariate analysis
(RR of knee pain)
Multivariate analysis*
(RR of knee pain)
Referent Referent
1.3 1.2
2.1 1.9
2.3 2.0
P for trend¼ 0.0009 P for trend¼ 0.006
Referent Referent
1.8 1.7
2.4 2.0
3.1 2.6
P for trend< 0.0001 P for trend¼ 0.0004
Referent Referent
1.9 1.4
1.9 1.5
2.3 1.9
P for trend¼ 0.20 P for trend¼ 0.22
res (e.g., for the max BML score analysis, results were adjusted for
Table IV
Associations of non-weight-bearing pain with maximal BML score, effusion score and synovitis score
Prevalence of knee pain
(non-weight-bearing pain)
Univariate analysis
(RR of knee pain)
Multivariate analysis
(RR of knee pain)*
Max BML score
0 3/14 (21.4%) Referent Referent
1 8/47 (17.0%) 0.8 0.8
2 11/36 (30.6%) 1.4 1.3
3 22/63 (34.9%) 1.6 1.5
P for trend¼ 0.06 P for trend¼ 0.15
Effusion score
0 5/26 (19.2%) Referent Referent
1 13/62 (21.0%) 1.1 1.0
2 18/55 (32.7%) 1.7 1.6
3 8/17 (47.1%) 2.5 2.1
P for trend¼ 0.02 P for trend¼ 0.04
Synovitis score
0 2/7 (28.6%) Referent Referent
1 22/79 (27.9%) 1.0 0.7
2 16/54 (29.6%) 1.0 0.8
3 4/20 (20.0%) 0.7 0.6
P for trend¼ 0.65 P for trend¼ 0.55
*Multivariate analysis results were adjusted for the other two MRI features.
1567Osteoarthritis and Cartilage Vol. 17, No. 12the measurement properties of these features will be neces-
sary to evaluate their performance longitudinally. Our ability
to ﬁnd an association between the maximal score of the
weight-bearing WOMAC pain questions and features on
MRI as measured by BLOKS provides validation for this
pain scoring method and for BLOKS.
In regards to the analyses evaluating the relationship be-
tween synovitis score and pain, it is notable that all the
levels of synovitis greater than zero did have RRs for pain
that were close to 2 or higher suggestive of an association
between synovitis and symptoms. However, the high prev-
alence of synovitis (153 of the 160 knees, 96%) led to insta-
bility of some of the RRs for pain in relation to synovitis.
Therefore, it is possible that there is a relationship between
synovitis and weight-bearing pain even though none of the
P-values reached a level of signiﬁcance (a< 0.05). Be-
cause there was a high prevalence of synovitis in this study,
it is unlikely that the result would have resulted in a signiﬁ-
cant association if synovitis were read using gadolinium-en-
hanced MRIs as the use of gadolinium usually increases
the sensitivity of synovitis. We did attempt to collapse those
with a synovitis score of 0 or 1 together into the same group,
but we found that the association was greatly diminished,
suggesting that including those in this lowest score of syno-
vitis is critical in seeing a relationship between synovitis and
pain. This relationship should to be re-evaluated in a sample
where a larger number of knees are free of any synovitis
and also using the symptom of morning stiffness.
In our study, we were surprised to ﬁnd that synovial effu-
sion and synovitis were not correlated because we had an-
ticipated, as others have, that they represented part of the
same pathology. The lack of correlation between these fea-
tures does not support this assumption. Without reading
multiple locations for synovitis in this particular study, we
cannot know if simpliﬁcation of the synovitis score led to
the lack of correlation between synovitis and joint effusion,
but it is a possibility. We did ﬁnd that synovitis does appear
to be a requisite for presence of an effusion in our data;
among the seven participants who had a synovitis score
of 0, six had minimal or no effusion. Conversely, almost
all knees with synovitis also had an effusion. The degree
of synovitis, however, does not appear to drive the degreeof effusion. Another possibility is that synovial effusion could
represent ﬂuid that has extravasated from bone in those
with BMLs. There is a weak correlation between BMLs
and synovial effusion that supports this possibility. These
explanations for our ﬁndings are purely speculative. A longi-
tudinal study evaluating these speciﬁc questions would be
necessary to examine these causal relationships.
Prior to this study, there has been controversy with regard
to whether BMLs are associated with pain. Previous studies
questioning the association of BML with knee pain, in knee
OA9,14e17 all used an absolute cut off (e.g., 1 cm and
>0 cm is a small lesion etc.) to provide semi-quantitative
BML scores. This is problematic because this scoring
schemedoes not take into account that people are of different
sizes and aBML that is 1 cm inmaximumdiameter in a 200 lb
person is not equivalent to a 1 cm BML in a 90 lb individual.
Though there has not been a head-to-head comparison of
these two types of scoring schemes, this difference could po-
tentially explain the inability to ﬁnd an association in selected
studieswhile the other studies3,12,13, including this one, using
a relative scale like BLOKS to grade BMLs (e.g.,<10%of po-
tential volume of involvement is a small lesion) have been
able to show an association between BMLs and symptoms.
There are several limitations to this study, one being that
this is a cross-sectional study, precluding our ability to draw
conclusions about temporal relationships between the oc-
currence of these features seen on MRI and the onset of
pain. Nevertheless, the existence of the strong relationship
between these features and pain in this study supports the
possibility that there is a causal relationship between the oc-
currence of these features and the occurrence of pain. An-
other limitation is that not all features of knee OA as seen
on MRI have been included in this analysis, including artic-
ular cartilage morphometry measures. The effort involved
in reading MRIs is considerable and we were constrained
to processing a small number of features. However, we did
intentionally select out BMLs, synovitis and effusion to in-
clude in this study because there was a biologic rationale
for our expectation that they would be associated with
pain. As with any epidemiologic study, there is a potential
limitation of confounding by unmeasured covariates but in
this situation, it is fairly unlikely because of the strength of
1568 G. H. Lo et al.: BMLs and joint effusion are associated with weight-bearing pain in knee OAthe observed associations. Our next step will be to conduct
a longitudinal study evaluating the causation of pain in knee
OA, assessing all potential causes of pain in knee OA. One
other consideration is that because this study was per-
formed in a convenience sample of participants of the OAI,
the associations seen in this study may not be representa-
tive of all those with knee OA. Nevertheless, it is still interest-
ing to observe that within this particular study sample, there
were independent associations of weight-bearing knee pain
with BMLs, synovial effusion, and perhaps synovitis.
Until recently, there has been an unwavering focus on the
articular cartilage to assess OA pathological severity. How-
ever, conﬂicting data exists with regard to whether cartilage
damage correlates well with pain13,37e39, and there was an
arthroscopic study that suggests that articular cartilage is in-
sensate40. This disconnect between cartilage damage and
symptoms has likely hindered our ability to identify effective
treatments in knee OA. A focus on articular cartilage as the
primary site of involvement in OA may have thus diverted
attention from clinically important pathological events in
other tissues that might be amenable to targeted interven-
tions. Indeed, our ﬁndings where we show that BMLs and
synovial effusion, and perhaps synovitis, are independently
associated with pain, support the notion that there are mul-
tiple sources of pain in knee OA. All these ﬁndings have the
potential to change and to predicate disease progression.
Investigators are obligated to study these aspects in longi-
tudinal studies to evaluate their suitability as treatment tar-
gets in knee OA in addition to or perhaps in lieu of
studying articular cartilage damage.Conﬂict of interest
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